Prospective Urban Rural Epidemiology Study
Launched by POPULATION HEALTH RESEARCH INSTITUTE · Jul 19, 2017
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
The Prospective Urban Rural Epidemiology Study is a research trial aimed at understanding how different factors affect our health, particularly focusing on heart diseases and other serious illnesses. Researchers want to learn about how personal choices, like what we eat and how active we are, as well as broader environmental factors, such as air quality and healthcare policies, influence health outcomes like disease development and mortality rates. The study will also look at genetic factors that may contribute to these non-communicable diseases.
If you're an adult aged between 35 and 70 and are interested in participating, you might be a good fit for this study. There are no specific exclusions, so virtually anyone in that age range can join. As a participant, you can expect to provide information about your health behaviors and possibly undergo some health assessments. This research is currently recruiting participants, and it aims to gather valuable insights that could improve our understanding of health across different communities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • consenting adults between 35-70 years of age
- Exclusion Criteria:
- • none
About Population Health Research Institute
The Population Health Research Institute (PHRI) is a leading clinical research organization dedicated to advancing the understanding of population health through innovative research methodologies. With a focus on large-scale, multi-center clinical trials and epidemiological studies, PHRI aims to address pressing health challenges by investigating the interplay between lifestyle, genetic, and environmental factors. By fostering collaboration among researchers, healthcare providers, and communities, PHRI strives to generate evidence-based insights that inform public health policies and improve health outcomes on a global scale. Their commitment to excellence in research is underscored by a robust infrastructure and a multidisciplinary team of experts dedicated to translating research findings into actionable solutions for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lima, , Peru
Karachi, , Pakistan
Harare, , Zimbabwe
Riyadh, , Saudi Arabia
Isfahan, , Iran, Islamic Republic Of
Hamilton, Ontario, Canada
Rosario, Santa Fe, Argentina
Dhaka, , Bangladesh
São Paulo, , Brazil
Vancouver, British Columbia, Canada
Ottawa, Ontario, Canada
Quebec City, Quebec, Canada
Temuco, , Chile
Beijing, , China
Floridablanca, Santander, Colombia
Bangalore, Karnataka, India
Thiruvananthapuram, Kerala, India
Jaipur, Rajasthan, India
Chennai, Tamil Nadu, India
Chandigarh, , India
Almaty, , Kazakhstan
Bishkek, , Kyrgyzstan
Kuala Lumpur, , Malaysia
Kuala Lumpur, , Malaysia
Ramallah, , Palestinian Territory, Occupied
Manila, , Philippines
Wrocław, , Poland
Kemerovo, , Russian Federation
Bellville, , South Africa
Potchefstroom, , South Africa
Göteborg, , Sweden
Moshi, , Tanzania
İstanbul, , Turkey
Dubai, , United Arab Emirates
Patients applied
Trial Officials
Salim Yusuf, DPhil
Principal Investigator
Executive Director
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials